Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 3 | 2023 | 415 | 2.070 |
Why?
|
| Chronic Pain | 8 | 2024 | 147 | 1.600 |
Why?
|
| Medicaid | 6 | 2023 | 267 | 1.480 |
Why?
|
| Medicare | 5 | 2023 | 241 | 1.300 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 1248 | 1.200 |
Why?
|
| Analgesics, Opioid | 10 | 2024 | 501 | 1.170 |
Why?
|
| United States | 23 | 2023 | 5217 | 1.120 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 127 | 0.870 |
Why?
|
| Conduct Disorder | 1 | 2022 | 17 | 0.860 |
Why?
|
| Back Pain | 2 | 2021 | 44 | 0.850 |
Why?
|
| Retrospective Studies | 25 | 2024 | 6432 | 0.840 |
Why?
|
| Intellectual Disability | 1 | 2023 | 149 | 0.840 |
Why?
|
| Pharmacy | 1 | 2023 | 64 | 0.820 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 164 | 0.800 |
Why?
|
| Aged | 22 | 2023 | 10054 | 0.800 |
Why?
|
| Students, Pharmacy | 1 | 2023 | 147 | 0.770 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2011 | 36 | 0.770 |
Why?
|
| Mental Disorders | 3 | 2015 | 451 | 0.750 |
Why?
|
| Education, Pharmacy | 1 | 2023 | 165 | 0.730 |
Why?
|
| Humans | 44 | 2024 | 54284 | 0.730 |
Why?
|
| Premature Birth | 1 | 2022 | 154 | 0.720 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 284 | 0.720 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 271 | 0.720 |
Why?
|
| Patient Care | 3 | 2023 | 61 | 0.670 |
Why?
|
| Prostate | 3 | 2023 | 117 | 0.650 |
Why?
|
| Osteoarthritis | 1 | 2018 | 71 | 0.620 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 642 | 0.600 |
Why?
|
| Female | 29 | 2023 | 28441 | 0.570 |
Why?
|
| Adult | 22 | 2024 | 14207 | 0.560 |
Why?
|
| Insurance Coverage | 2 | 2020 | 107 | 0.560 |
Why?
|
| Antipsychotic Agents | 3 | 2014 | 247 | 0.550 |
Why?
|
| Male | 25 | 2023 | 27334 | 0.540 |
Why?
|
| Bupropion | 1 | 2015 | 30 | 0.530 |
Why?
|
| Pneumococcal Vaccines | 1 | 2015 | 10 | 0.520 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2015 | 9 | 0.520 |
Why?
|
| Quality of Life | 2 | 2018 | 922 | 0.510 |
Why?
|
| Community-Acquired Infections | 1 | 2015 | 42 | 0.510 |
Why?
|
| SEER Program | 3 | 2023 | 91 | 0.500 |
Why?
|
| Adolescent | 11 | 2023 | 6897 | 0.500 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 42 | 0.500 |
Why?
|
| Drug Overdose | 4 | 2022 | 154 | 0.500 |
Why?
|
| Middle Aged | 20 | 2021 | 13088 | 0.480 |
Why?
|
| Alcoholism | 3 | 2021 | 249 | 0.480 |
Why?
|
| Atrial Fibrillation | 2 | 2015 | 197 | 0.450 |
Why?
|
| Tramadol | 2 | 2024 | 29 | 0.450 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 89 | 0.440 |
Why?
|
| Young Adult | 10 | 2020 | 4318 | 0.440 |
Why?
|
| Tobacco Use Cessation | 1 | 2012 | 8 | 0.430 |
Why?
|
| Polypharmacy | 1 | 2011 | 15 | 0.420 |
Why?
|
| Smoking Cessation | 1 | 2015 | 316 | 0.410 |
Why?
|
| Practice Management, Medical | 1 | 2011 | 13 | 0.410 |
Why?
|
| Neoplasms | 1 | 2022 | 1316 | 0.410 |
Why?
|
| Minority Groups | 2 | 2023 | 136 | 0.400 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 87 | 0.400 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 3431 | 0.400 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 105 | 0.390 |
Why?
|
| Medical Informatics | 1 | 2011 | 55 | 0.390 |
Why?
|
| Smoking | 1 | 2015 | 556 | 0.380 |
Why?
|
| Emergency Service, Hospital | 2 | 2016 | 539 | 0.380 |
Why?
|
| Attitude to Computers | 1 | 2010 | 23 | 0.370 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 46 | 0.360 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 140 | 0.350 |
Why?
|
| Opioid-Related Disorders | 3 | 2022 | 367 | 0.340 |
Why?
|
| Acetaminophen | 1 | 2011 | 349 | 0.300 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 1693 | 0.300 |
Why?
|
| Health Services Accessibility | 2 | 2022 | 432 | 0.290 |
Why?
|
| Propensity Score | 4 | 2022 | 137 | 0.290 |
Why?
|
| Health Care Surveys | 3 | 2011 | 195 | 0.290 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 397 | 0.280 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 642 | 0.260 |
Why?
|
| Odds Ratio | 4 | 2020 | 604 | 0.260 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 671 | 0.240 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2021 | 61 | 0.240 |
Why?
|
| Ileus | 1 | 2023 | 16 | 0.240 |
Why?
|
| Arkansas | 5 | 2022 | 2100 | 0.230 |
Why?
|
| Cohort Studies | 6 | 2022 | 1543 | 0.230 |
Why?
|
| Obesity | 1 | 2011 | 1202 | 0.220 |
Why?
|
| Child | 4 | 2023 | 7341 | 0.220 |
Why?
|
| Confidence Intervals | 3 | 2013 | 167 | 0.220 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 204 | 0.220 |
Why?
|
| Neuralgia | 1 | 2023 | 58 | 0.210 |
Why?
|
| Prescriptions | 1 | 2021 | 9 | 0.210 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 164 | 0.210 |
Why?
|
| Health Expenditures | 1 | 2022 | 67 | 0.210 |
Why?
|
| Neck Pain | 1 | 2021 | 8 | 0.200 |
Why?
|
| Radiation Injuries | 1 | 2023 | 153 | 0.200 |
Why?
|
| Arthralgia | 1 | 2021 | 50 | 0.200 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 52 | 0.200 |
Why?
|
| Heart Diseases | 1 | 2023 | 237 | 0.190 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2020 | 7 | 0.190 |
Why?
|
| Anxiety | 1 | 2022 | 279 | 0.180 |
Why?
|
| Hypertension | 2 | 2018 | 564 | 0.180 |
Why?
|
| Registries | 1 | 2023 | 553 | 0.180 |
Why?
|
| Veterans | 5 | 2021 | 629 | 0.180 |
Why?
|
| Curriculum | 1 | 2023 | 429 | 0.180 |
Why?
|
| Hawaii | 1 | 2020 | 126 | 0.180 |
Why?
|
| Preventive Health Services | 1 | 2020 | 53 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 643 | 0.170 |
Why?
|
| Insurance, Health | 1 | 2020 | 132 | 0.170 |
Why?
|
| Arterial Pressure | 1 | 2018 | 50 | 0.160 |
Why?
|
| Sleep Deprivation | 1 | 2018 | 16 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 492 | 0.160 |
Why?
|
| Vancomycin | 1 | 2018 | 88 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 88 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 44 | 0.150 |
Why?
|
| Shock, Septic | 1 | 2018 | 80 | 0.150 |
Why?
|
| Logistic Models | 2 | 2011 | 995 | 0.150 |
Why?
|
| Risk Factors | 4 | 2018 | 3935 | 0.150 |
Why?
|
| Depression | 1 | 2022 | 595 | 0.150 |
Why?
|
| Ganciclovir | 1 | 2016 | 35 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2016 | 30 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2016 | 46 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 67 | 0.140 |
Why?
|
| Inappropriate Prescribing | 1 | 2016 | 20 | 0.140 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 426 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2016 | 188 | 0.130 |
Why?
|
| Nicotinic Agonists | 1 | 2015 | 60 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 74 | 0.130 |
Why?
|
| Length of Stay | 2 | 2015 | 683 | 0.130 |
Why?
|
| Hospitals, Veterans | 1 | 2015 | 127 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 188 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2014 | 84 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 2387 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 75 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 403 | 0.120 |
Why?
|
| Hydrocodone | 2 | 2024 | 17 | 0.120 |
Why?
|
| Oxycodone | 2 | 2024 | 24 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 41 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2015 | 270 | 0.110 |
Why?
|
| Insurance Claim Review | 1 | 2012 | 28 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 476 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 820 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2011 | 4147 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2015 | 465 | 0.110 |
Why?
|
| Drug Substitution | 1 | 2011 | 11 | 0.100 |
Why?
|
| Office Visits | 1 | 2011 | 49 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 51 | 0.100 |
Why?
|
| Hospitalization | 1 | 2016 | 705 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1084 | 0.100 |
Why?
|
| Linear Models | 1 | 2011 | 309 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2011 | 95 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2011 | 445 | 0.090 |
Why?
|
| Physicians' Offices | 1 | 2010 | 4 | 0.090 |
Why?
|
| Information Systems | 1 | 2010 | 27 | 0.090 |
Why?
|
| Body Weight | 1 | 2013 | 578 | 0.090 |
Why?
|
| Weight Gain | 1 | 2011 | 243 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2011 | 230 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2013 | 489 | 0.090 |
Why?
|
| Patients | 1 | 2010 | 53 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 232 | 0.090 |
Why?
|
| Comorbidity | 1 | 2011 | 663 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2021 | 246 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 3213 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2010 | 259 | 0.080 |
Why?
|
| Guideline Adherence | 2 | 2023 | 148 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 309 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 1198 | 0.070 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2020 | 315 | 0.070 |
Why?
|
| Incidence | 2 | 2018 | 1082 | 0.060 |
Why?
|
| Anastomotic Leak | 1 | 2023 | 10 | 0.060 |
Why?
|
| Colectomy | 1 | 2023 | 33 | 0.060 |
Why?
|
| Biological Factors | 1 | 2023 | 13 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 1025 | 0.060 |
Why?
|
| Heart Atria | 1 | 2023 | 57 | 0.060 |
Why?
|
| Infant | 1 | 2011 | 3817 | 0.060 |
Why?
|
| Accidents | 1 | 2021 | 24 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2022 | 171 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2023 | 242 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2015 | 684 | 0.050 |
Why?
|
| Heart | 1 | 2023 | 360 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 66 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2023 | 1228 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 405 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1304 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2020 | 154 | 0.040 |
Why?
|
| Mastectomy | 1 | 2020 | 143 | 0.040 |
Why?
|
| Goals | 1 | 2018 | 50 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 327 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2020 | 159 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 222 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 735 | 0.040 |
Why?
|
| Physicians | 1 | 2021 | 247 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2016 | 28 | 0.040 |
Why?
|
| Health Surveys | 1 | 2018 | 263 | 0.040 |
Why?
|
| Opportunistic Infections | 1 | 2016 | 58 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2023 | 1033 | 0.040 |
Why?
|
| Rats | 1 | 2023 | 3415 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 951 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2016 | 161 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 746 | 0.030 |
Why?
|
| Geriatrics | 1 | 2016 | 47 | 0.030 |
Why?
|
| Critical Illness | 1 | 2018 | 344 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 109 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 194 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 133 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 74 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 102 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 106 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 188 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 184 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 690 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2013 | 85 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 1361 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 14385 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5604 | 0.020 |
Why?
|